Intracranial Delivery of the Nitric Oxide Donor Diethylenetriamine/Nitric Oxide from a Controlled-Release Polymer: Toxicity in Cynomolgus Monkeys

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurosurgery

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1227/01.NEU.0000210182.48546.8FPMID 16639332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates.

  2006cited by this paper
• Subarachnoid haemorrhage induced proliferation of leptomeningeal cells and deposition of extracellular matrices in the arachnoid granulations and subarachnoid space

  2005cited by this paper
• Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH

  2005cited by this paper
• Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.

  2005cited by this paper
• Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates.

  2005cited by this paper
• The international cooperative study on timing of aneurysm surgery

  2005cited by this paper
• Delayed Intracranial Delivery of a Nitric Oxide Donor from a Controlled-release Polymer Prevents Experimental Cerebral Vasospasm in Rabbits

  2004cited by this paper
• Effects of a Nitric Oxide Donor on and Correlation of Changes in Cyclic Nucleotide Levels with Experimental Vasospasm

  2003cited by this paper
• Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions

  2002cited by this paper
• Prevention of Experimental Cerebral Vasospasm by Intracranial Delivery of a Nitric Oxide Donor From a Controlled-Release Polymer: Toxicity and Efficacy Studies in Rabbits and Rats

  2002cited by this paper
• Intracisternal Sodium Nitroprusside Fails to Prevent Vasospasm in Nonhuman Primates

  2002cited by this paper
• Prevention and Reversal of Experimental Posthemorrhagic Vasospasm by the Periadventitial Administration of Nitric Oxide from a Controlled-release Polymer

  2001cited by this paper
• Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans.

  2000cited by this paper
• Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.

  1999cited by this paper
• Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers.

  1999cited by this paper
• Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.

  1998cited by this paper
• Reactions between nitric oxide and haemoglobin under physiological conditions

  1998cited by this paper
• Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage.

  1998cited by this paper
• Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage.

  1997cited by this paper
• Aneurysmal subarachnoid hemorrhage: prognostic features and outcomes.

  1997cited by this paper
• Neuropathological Changes in Chronic Adult Hydrocephalus: Cortical Biopsies and Autopsy Findings

  1997cited by this paper
• Low lead levels stunt neuronal growth in a reversible manner.

  1996cited by this paper
• Cerebral arterial spasm--a clinical review.

  1995cited by this paper
• NMDA-receptor antagonists disrupt the formation of the auditory space map in the mammalian superior colliculus

  1995cited by this paper
• Interstitial Drug Delivery to the Central Nervous System Using Controlled Release Polymers: Chemotherapy for Brain Tumors

  1994cited by this paper
• A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects.

  1994cited by this paper
• The effect of intrathecal sodium nitroprusside on severe chronic vasospasm.

  1993cited by this paper
• A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

  1993cited by this paper
• The International Cooperative Study on the Timing of Aneurysm Surgery: The North American Experience

  1992cited by this paper
• Treatment of cerebral vasospasm with intra-arterial papaverine.

  1992cited by this paper
• Involvement of the N-methyl D-aspartate (NMDA) receptor in synapse elimination during cerebellar development.

  1992cited by this paper
• Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.

  1991cited by this paper
• Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema.

  1991cited by this paper
• Cerebral vasospasm.

  1990cited by this paper
• Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm.

  1989cited by this paper
• Time-dependent effects of extraluminally-applied oxyhemoglobin and endothelial removal on vasodilator responses in isolated, perfused canine basilar arteries.

  1989cited by this paper
• Controlled release of dopamine from a polymeric brain implant: In vivo characterization

  1989cited by this paper
• Blockade of endothelium-dependent vasodilation by hemoglobin: a possible factor in vasospasm associated with hemorrhage.

  1985cited by this paper
• Leukocytosis and subarachnoid hemorrhage.

  1984cited by this paper
• Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

  1983cited by this paper
• Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension.

  1983cited by this paper
• Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension.

  1982cited by this paper
• Biocompatibility of polymeric delivery systems for macromolecules.

  1981cited by this paper
• Polymers for the sustained release of proteins and other macromolecules

  1976cited by this paper
• Postoperative hypertension in the management of patients with intracranial arterial aneurysms.

  1976cited by this paper
• Cerebral vasospasm.

  1976cited by this paper
• Chronic communicating hydrocephalus with normal CSE pressures: a cisternographic-pathologic correlation.

  1974cited by this paper
• The treatment of recurrent cerebrovascular symptoms and the question of "vasospasm".

  1951cited by this paper

• Manufacturing and testing of a polymer formulation for long-time release delivery of antisense oligonucleotides in hiPSC-derived motoneurons

  2026cites this paper
• Meningeal Immunity: Structure, Function and a Potential Therapeutic Target of Neurodegenerative Diseases.

  2021cites this paper
• The effect of L-arginine therapy on vasospasm: an experimental study in rats.

  2019cites this paper
• Role of nitric oxide and mechanisms involved in cerebral injury after subarachnoid hemorrhage: is nitric oxide a possible answer to cerebral vasospasm?

  2016cites this paper
• Untersuchung zur lokalen antivasospastischen Wirkung von Nimodipin slow-release Systemen nach experimenteller Subarachnoidalblutung an der Ratte

  2014cites this paper
• Nitric Oxide in Cerebral Vasospasm: Theories, Measurement, and Treatment

  2013cites this paper
• Site-Specific, Sustained-Release Drug Delivery for Subarachnoid Hemorrhage

  2012cites this paper
• Polymer‐Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications

  2012cites this paper
• Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation.

  2011cites this paper
• Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates.

  2011cites this paper
• Just say NO to vasospasm.

  2011cites this paper
• CONTROLLED DELIVERY OF NITRIC OXIDE INHIBITS LEUKOCYTE MIGRATION AND PREVENTS VASOSPASM IN HAPTOGLOBIN 2‐2 MICE AFTER SUBARACHNOID HEMORRHAGE

  2009cites this paper
• Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid. Laboratory investigation.

  2009cites this paper
• Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought

  2009cites this paper
• [Basic research and treatment for cerebral vasospasm after subarachnoid hemorrhage: the present and future prospects].

  2008cites this paper
• TREATMENT OF CEREBRAL VASOSPASM WITH BIOCOMPATIBLE CONTROLLED‐RELEASE SYSTEMS FOR INTRACRANIAL DRUG DELIVERY

  2008cites this paper
• Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo

  2008cites this paper
• The effect of an intracisternal nimodipine slow-release system on cerebral vasospasm after experimental subarachnoid haemorrhage in the rat

  2008cites this paper
• Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding.

  2007cites this paper